MissionIR Articles

Fluoropharma is a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. FPMI’s initial focus is the development of breakthrough positron…

Organovo Holdings is a 3D biology company focused on delivering bioprinting technology and creating tissue on demand for research and medical applications. The company’s NovoGen 3D bioprinting technology is a platform that works across all…

Bio Specifics Technologies is the developer of an injectable collagenase, XIAFLEX®, for 12 clinical indications. Currently, XIAFLEX is marketed in the U.S. for the treatment of adult Dupuytren’s contracture patients with a palpable cord by…

VentriPoint Diagnostics is a medical device company engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease primarily in Canada and Europe. The company’s VentriPoint Diagnostic System is used to…

Lpath is a biotech company focused on the discovery and development of lipidomic-based therapeutic antibodies for treating human diseases primarily in the United States. LPTN’s lead product candidate, iSONEPTM, is currently in two clinical trials…

Tonix Pharmaceuticals Holding is a development-stage specialty pharmaceutical company focused on the development of pharmaceutical products for central nervous system conditions. The company’s lead product candidates include TNX-102, for the management of fibromyalgia syndrome; and…

Rosetta Genomics is a molecular diagnostics company that develops and commercializes a range of microRNA-based molecular diagnostic tests. ROSG’s product portfolio includes: miRview®lung,  miRview®squamos, miRview®meso and miRview®kidney. The company also has a collaboration agreement with…

Galectin Therapeutics is a development-stage company engaged in developing carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer. GALT also has a colorectal cancer program moving toward commercialization. The company’s lead product candidate…

Synergy Pharmaceuticals is developing new drugs to treat gastrointestinal disorders and diseases. Plecanatide, the company’s lead proprietary drug candidate, functions by activating the guanylate cyclase C receptor on epithelial cells of the GI tract. Synergy…

IntelGenx Technologies is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IGXT has also developed novel delivery technologies for the rapid delivery of…

TrovaGene is the developer of patented technology for the detection of transrenal DNA and RNA, short nucleic acid fragments, originating from normal and diseased cell death that cross the kidney barrier and can be detected…

Cel-Sci is focused on the research and development of improvements in the treatment of cancer and other diseases by utilizing the body’s immune system. Its lead investigational therapy, Multikine, is currently being studied in a…

AtheroNova is an early-stage biotech company focused on the discovery, research, development and licensing of novel compounds designed to reduce or eliminate atherosclerotic plaque deposits. The company is currently completing two additional studies to validate…